Decentralized by Design: Optimizing Trials for Remote Conduct

In our January 25 webinar, Decentralized by Design: Optimizing Trials for Remote Conduct, our clinical science experts shared key learnings from Signant’s rich heritage of supporting decentralized trial (DCT) methods. Our presenters Bill Byrom, PhD, Dan DeBonis, and Todd Everhart, MD, discussed the thoughtful application of decentralized strategies and solutions that can optimize remote trial conduct in any setting while ensuring high-quality evidence generation.

Learn more from the company that has over 20 years of experience supporting DCT by tuning in to the webinar below.